PF9

2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline

Find entries where: PF9

is present as a standalone ligand in 2 entries

Find related ligands:

Chemical Component Summary
Name	2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline
Identifiers	2-[[4-(1-methyl-4-pyridin-4-yl-pyrazol-3-yl)phenoxy]methyl]quinoline
Formula	C₂₅ H₂₀ N₄ O
Molecular Weight	392.453
Type	NON-POLYMER
Isomeric SMILES	Cn1cc(c(n1)c2ccc(cc2)OCc3ccc4ccccc4n3)c5ccncc5
InChI	InChI=1S/C25H20N4O/c1-29-16-23(18-12-14-26-15-13-18)25(28-29)20-7-10-22(11-8-20)30-17-21-9-6-19-4-2-3-5-24(19)27-21/h2-16H,17H2,1H3
InChIKey	AZEXWHKOMMASPA-UHFFFAOYSA-N

Chemical Details
Formal Charge	0
Atom Count	50
Chiral Atom Count	0
Bond Count	54
Aromatic Bond Count	30

Drug Info: DrugBank

DrugBank ID	DB08387
Name	Mardepodect
Groups	investigational
Synonyms	Mardepodect succinate 2-[4-(1-Methyl-4-pyridin-4-yl-lH-pyrazol-3-yl)-phenoxymethyl]-quinoline succinic acid Mardepodect
Categories	Heterocyclic Compounds, Fused-Ring
CAS number	898562-94-2

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A	MRIEERKSQHLTGLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRK...	unknown

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682